The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Genetics of Obesity and Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Diabetologia. 2023 Jan;66(1):116-126. doi: 10.1007/s00125-022-05806-2. Epub 2022 Oct 11.
AIMS/HYPOTHESIS: We examined the contribution of rare HNF1A variants to type 2 diabetes risk and age of diagnosis, and the extent to which their impact is affected by overall genetic susceptibility, across three ancestry groups.
Using exome sequencing data of 160,615 individuals of the UK Biobank and 18,797 individuals of the BioMe Biobank, we identified 746 carriers of rare functional HNF1A variants (minor allele frequency ≤1%), of which 507 carry variants in the functional domains. We calculated polygenic risk scores (PRSs) based on genome-wide association study summary statistics for type 2 diabetes, and examined the association of HNF1A variants and PRS with risk of type 2 diabetes and age of diagnosis. We also tested whether the PRS affects the association between HNF1A variants and type 2 diabetes risk by including an interaction term.
Rare HNF1A variants that are predicted to impair protein function are associated with increased risk of type 2 diabetes in individuals of European ancestry (OR 1.46, p=0.049), particularly when the variants are located in the functional domains (OR 1.89, p=0.002). No association was observed for individuals of African ancestry (OR 1.10, p=0.60) or Hispanic-Latino ancestry (OR 1.00, p=1.00). Rare functional HNF1A variants were associated with an earlier age at diagnosis in the Hispanic-Latino population (β=-5.0 years, p=0.03), and this association was marginally more pronounced for variants in the functional domains (β=-5.59 years, p=0.03). No associations were observed for other ancestries (African ancestry β=-2.7 years, p=0.13; European ancestry β=-3.5 years, p=0.20). A higher PRS was associated with increased odds of type 2 diabetes in all ancestries (OR 1.61-2.11, p<10) and an earlier age at diagnosis in individuals of African ancestry (β=-1.4 years, p=3.7 × 10) and Hispanic-Latino ancestry (β=-2.4 years, p<2 × 10). Furthermore, a higher PRS exacerbated the effect of the functional HNF1A variants on type 2 diabetes in the European ancestry population (p=0.037).
CONCLUSIONS/INTERPRETATION: We show that rare functional HNF1A variants, in particular those located in the functional domains, increase the risk of type 2 diabetes, at least among individuals of European ancestry. Their effect is even more pronounced in individuals with a high polygenic susceptibility. Our analyses highlight the importance of the location of functional variants within a gene and an individual's overall polygenic susceptibility, and emphasise the need for more genetic data in non-European populations.
目的/假设:我们研究了罕见的 HNF1A 变异在 2 型糖尿病风险和诊断年龄中的作用,以及它们的影响在多大程度上受到整体遗传易感性的影响,在三个祖裔群体中进行了研究。
使用英国生物银行的 160615 名个体和 BioMe 生物银行的 18797 名个体的外显子组测序数据,我们鉴定了 746 名罕见功能 HNF1A 变异(次要等位基因频率≤1%)的携带者,其中 507 名携带功能域内的变异。我们基于 2 型糖尿病的全基因组关联研究汇总统计数据计算了多基因风险评分(PRSs),并研究了 HNF1A 变异和 PRS 与 2 型糖尿病风险和诊断年龄的关联。我们还通过包含交互项来检验 PRS 是否影响 HNF1A 变异与 2 型糖尿病风险之间的关联。
预测会损害蛋白质功能的罕见 HNF1A 变异与欧洲血统个体的 2 型糖尿病风险增加相关(OR 1.46,p=0.049),特别是当变异位于功能域时(OR 1.89,p=0.002)。在非洲血统个体(OR 1.10,p=0.60)或西班牙裔-拉丁裔个体(OR 1.00,p=1.00)中未观察到关联。罕见的功能性 HNF1A 变异与西班牙裔-拉丁裔人群的诊断年龄较早有关(β=-5.0 岁,p=0.03),并且在功能域内的变异中这种关联更为明显(β=-5.59 岁,p=0.03)。在其他祖裔群体中未观察到关联(非洲血统β=-2.7 岁,p=0.13;欧洲血统β=-3.5 岁,p=0.20)。较高的 PRS 与所有祖裔人群的 2 型糖尿病发病风险增加相关(OR 1.61-2.11,p<10),与非洲血统个体(β=-1.4 岁,p=3.7×10)和西班牙裔-拉丁裔个体(β=-2.4 岁,p<2×10)的诊断年龄较早有关。此外,较高的 PRS 加剧了功能性 HNF1A 变异对欧洲血统人群 2 型糖尿病的影响(p=0.037)。
结论/解释:我们表明,罕见的功能性 HNF1A 变异,特别是位于功能域内的变异,会增加 2 型糖尿病的风险,至少在欧洲血统个体中如此。在具有较高多基因易感性的个体中,这种影响更为明显。我们的分析强调了功能变异在基因内位置和个体整体多基因易感性的重要性,并强调了在非欧洲人群中需要更多的遗传数据。